We are proud to share that PRELIQX has been selected as one of the Top 15 Innovators in the Open Innovation Challenge 2025, organized by the Diabetes Center Berne (DCB).
Out of more than 50 international submissions, Nephronin, our precision diagnostic solution for early detection of kidney injury; especially in patients with diabetes; was recognized for its innovation and clinical relevance.
This milestone marks an important step forward in our mission to advance non-invasive, liquid biopsy-based diagnostics that enable earlier detection and better treatment decisions in chronic disease management.
We thank the Diabetes Center Berne and the selection committee for this opportunity and look forward to the upcoming phases of the challenge, including collaboration, expert exchange, and innovation mentoring.
Stay tuned for more updates as we move forward!
